## Clinical Assessment of BPH **Key Point:** Diagnosis of BPH is primarily clinical (history + DRE + PSA). Investigations are tailored to severity, failure of medical therapy, and surgical planning. ## Investigation Hierarchy in BPH ### Baseline Investigations (Recommended) **High-Yield:** Standard workup includes: 1. **IPSS score** (International Prostate Symptom Score) — quantifies LUTS severity 2. **Uroflowmetry** — measures peak flow rate (Qmax); normal >15 mL/s, obstructed <10 mL/s 3. **Post-void residual (PVR)** — ultrasound or catheterization; elevated PVR suggests obstruction 4. **Serum PSA** — cancer screening; does not predict BPH severity 5. **Renal function and urinalysis** — exclude other pathology ### Imaging for Prostate Volume Estimation **Clinical Pearl:** Transrectal ultrasound (TRUS) is **NOT the first-line imaging modality** in routine BPH evaluation. - **Transabdominal (suprapubic) ultrasound** is the standard first-line imaging for prostate volume estimation in BPH — it is non-invasive, widely available, and sufficient for most clinical decisions. - **TRUS** is reserved for specific indications: abnormal DRE, elevated PSA (to guide biopsy), or when precise volume measurement is required for surgical planning (e.g., deciding between TURP and open prostatectomy) and transabdominal ultrasound is inadequate. - TRUS is more accurate than transabdominal ultrasound but is invasive and not universally required as a first-line modality. - According to EAU and AUA guidelines, TRUS is not recommended as a routine first-line investigation in uncomplicated BPH. **Why Option B is Incorrect:** Stating that TRUS is "recommended as the first-line imaging modality" is factually inaccurate. Transabdominal ultrasound serves as the first-line imaging approach; TRUS is a second-line or selective tool. ### Urodynamic Studies: When NOT Routinely Indicated **Warning:** Urodynamic studies (cystometrography, pressure-flow studies) are **NOT recommended as routine preoperative investigations** in uncomplicated BPH — however, they are appropriate in selected cases. **High-Yield:** Urodynamics are reserved for: - Suspected **detrusor dysfunction** (neurogenic bladder, spinal cord injury) - **Recurrent UTI** or upper tract dilatation - **Failed TURP** or persistent symptoms post-surgery - Atypical presentations (young age, neurological history) In this patient with straightforward BPH, urodynamics are not the first choice but are not categorically inappropriate before surgery — guidelines do support their use when detrusor dysfunction needs to be excluded prior to surgical intervention. ### Surgical Intervention Indications **Key Point:** Surgery is indicated when: - Medical therapy fails or is not tolerated - Recurrent UTI attributable to BPH - Recurrent gross hematuria from BPH - Bladder stones - Upper tract dilatation - Refractory retention This patient has moderate LUTS and elevated PVR (120 mL). **TURP is appropriate if medical therapy fails**, and uroflowmetry is a standard baseline investigation. ## Summary: What IS vs. IS NOT Routinely Done | Investigation | Routine in BPH? | Rationale | | --- | --- | --- | | IPSS score | Yes | Quantifies symptom severity | | Uroflowmetry | Yes | Establishes baseline Qmax, confirms obstruction | | Transabdominal US | Yes | First-line imaging for prostate volume | | TRUS | **No (not first-line)** | Reserved for biopsy guidance, elevated PSA, or precise surgical planning | | Urodynamics | Selective | For atypical cases, suspected detrusor dysfunction | **Why Option B is the EXCEPT answer:** TRUS is not the "first-line imaging modality" for BPH. Transabdominal ultrasound is the standard non-invasive first-line imaging. TRUS is an invasive procedure reserved for specific indications such as guiding prostate biopsy (elevated PSA/abnormal DRE) or precise volume measurement when transabdominal imaging is insufficient. Recommending TRUS as the universal first-line imaging in all BPH patients is not supported by EAU, AUA, or standard surgical textbooks (Campbell-Walsh Urology).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.